Vicore Pharma Holding AB (publ) (STO:VICO)

Vicore Pharma Holding AB Revenue

Vicore Pharma Holding AB had revenue of 602.00K SEK in the quarter ending March 31, 2026, a decrease of -32.51%. This brings the company's revenue in the last twelve months to 3.53M, down -41.17% year-over-year. In the year 2025, Vicore Pharma Holding AB had annual revenue of 3.82M, down -96.51%.

• Revenue (ttm): 3.53M
• Revenue Growth: -41.17%
• P/S Ratio: 951.46
• Revenue / Employee: 95.32K
• Employees: 37
• Market Cap: 3.36B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.82M	-105.53M	-96.51%
Dec 31, 2024	109.35M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 23, 2026

Data Sources Report a data error